Robert Klitzman, MD, professor of psychiatry, addresses the ethical and health concerns that must be considered in tackling the obesity epidemic and broader public health challenges.
A Columbia study shows a simple smell test and memory exam can predict cognitive decline as accurately as costly brain imaging, offering a more affordable and accessible way to assess dementia.
“This study strongly indicates the feasibility of using multimodal MRI—particularly diffusion MRI–based analysis of the structural connectome—to accurately predict Alzheimer’s risk,” said Jiook Cha.
“Mitochondria are the missing link between our psychological state and neurological or other disorders involving inflammation,” says Dr. Martin Picard.
“A good deal of the demonization of people with mental disorders stems from a marked overestimation of their risk of violence,” says Dr. Paul Applebaum.
Dr. Sander Markx and Dr. Job de Jong are hoping their work on mini brains could lead to a pioneering study using stem cells to find and test new treatments for psychiatric disorders.
Kristina Denisova, PhD specializes in state of the art brain imaging of children at risk for Autism Spectrum Disorders (ASD) at Columbia University Irving Medical Center.
The Columbia Suicide Severity Rating Scale (C-SSRS) was primarily developed Dr. Kelly Posner as a tool to screen for suicidality in medication research trials.
“We are thrilled about our new partners and the opportunity to apply our biotechnology platform at the scale needed to identify new drugs for neuropsychiatric disorders,” said Dr. Sean Escola.